US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
アメリカ
NYSE
Fs Credit Opportunities Corp (FSCO) 銘柄情報

Fs Credit Opportunities Corp (FSCO)

4.88

0.03

(0.62%)

終了 7月11日 5:00AM

4.93

0.05

(1.02%)

取引時間後: 7:24AM

Fs Credit Opportunities Corp (FSCO) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

4.93

( 1.65% )

買値

-

売値

-

出来高

595,499

4.84 日の範囲 4.91

4.13 52 週間の範囲 7.65

前日終値

4.85

始値

4.84

時刻

最終取引時間

平均取引量 (3 か月)

1,066,275

財務取引量

US$ 2,908,303

VWAP

4.8838

FS Credit Opportunities Corp. (FSCO) Declares Distribution for July 2026

FS Credit Opportunities Corp. (FSCO) Declares Distribution for July 2026 PR Newswire PHILADELPHIA, July 8...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFR14A - Revised definitive proxy soliciting materials

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

FS Credit Opportunities Corp. (FSCO) Declares Distribution for June 2026

FS Credit Opportunities Corp. (FSCO) Declares Distribution for June 2026 PR Newswire PHILADELPHIA, June 9...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.02	-0.40404040404	4.95	4.99	4.82	800140	4.89173669	CS
4	0	0	4.93	5.025	4.69	974229	4.88191785	CS
12	-0.32	-6.09523809524	5.25	5.3449	4.6713	1066275	4.99098844	CS
26	-1.49	-23.2087227414	6.42	6.52	4.13	1566567	5.1724937	CS
52	-2.28	-31.6227461859	7.21	7.65	4.13	1469631	5.89809271	CS
156	0.02	0.40733197556	4.91	7.65	4.13	994069	6.06544917	CS
260	-0.07	-1.4	5	7.65	3.8	927092	5.89295327	CS

FSCO - Frequently Asked Questions (FAQ)

What is the current Fs Credit Opportunities Corp share price?

The current share price of Fs Credit Opportunities Corp is US$ 4.93

What is the 1 year trading range for Fs Credit Opportunities Corp share price?

Fs Credit Opportunities Corp has traded in the range of US$ 4.13 to US$ 7.65 during the past year

rosemountbomber

rosemountbomber 8分前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 10分前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

BahamaPete

BahamaPete 20分前

Thanks OCKHAM's RAZOR, I added your links to my DD post. Go $TKOI

Helter Skelter

Helter Skelter 29分前

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

Twiggs333

Twiggs333 36分前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Popeye 36分前

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 38分前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 41分前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 50分前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 1時間前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Real McCoy

Real McCoy 1時間前

Well yeah this one has the most lies.

3rd attempt: you ok with lies, yes or no?

pos_stock_hoarder

pos_stock_hoarder 1時間前

New York Dolls - Looking for a Kiss

https://youtu.be/GvmvMFXWzc8

Genz2

Genz2 1時間前

https://techcrunch.com/2026/07/10/us-cyber-agency-cisa-had-to-build-its-incident-playbook-during-the-incident-agency-reveals/

According to Krebs, the researcher tried to alert the contractor but didn’t hear back. Only after Krebs contacted CISA did the agency take the repository offli

boston127

boston127 1時間前

Hey,

Thanks for the links you sent me. My PC blocked all of the URLs due to malware protection. I'm still in GNIS and the other one. I was up but they have dive bombed quite rapidly. Now, in the RED. Both companies are interesting.

LTR

I have an idea AF may turn up in discovery when the dots are lined up and connected. AF may look to be a witness in order to avoid being a defendent.

conix

conix 1時間前

Non-promotional information until there is a press release is a wise move.

CatfishHunter

CatfishHunter 1時間前

We should have news of next step well before years end. Vivos is already approved by FDA to start the EFS. Mayo Clinic needs to review and sign off on the approved conditions for the IRB and that’s just a formality. EFS could start as early as August. And 30 day patient status report about 45 days a

Philosophical Trader

Philosophical Trader 1時間前

How is this doing? This was a great runner with a 2 year cup and handle.

nwtf

nwtf 1時間前

You really dont have a clue what you are talking about. Just stop.

Fs Credit Opportunities

Learn CW Investment

FTSE NSX Overall Consume...

Horizon Quantum

JPMorgan BetaBuilders US...

Bulgarska roza AD Karlovo

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。